TREYSTA MEDICAL TECHNOLOGIES INC

GAINESILLE, FL · Founded 2025 · CIK 0002057780 · Medtech · Private

Topical drug formulation for prevention and reduction of post-surgical scarring

treystamedicaltechnologies.com →
Grants
$305K
1 award
Sector median: 1
Raised
$183K
2 Form D · Feb 2026
8 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Development of a Burn Care Therapy to Prevent Fibrotic Pathologies$304,984
Private capital raisedForm D · SEC$92,500
Private capital raisedForm D · SEC$90,000
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1606NV MEDTECH, Inc.—$21M
1607Emblok, Inc.—$6.0M
1608CereVu Medical, Inc.——
1609TREYSTA MEDICAL TECHNOLOGIES INC—$183K
1610AROMHA, INC.—$425K
1611WR Biotech, LLC——
1612Buck Surgical, Inc.—$300K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Marcelo BuzziDirector · Executive Officer
  • Nathan ZarnstorffDirector · Executive Officer

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.